The Trump administration's budget proposal for 2026 looks to make cuts to HIV prevention in clinics and community ...

In a recent decision, the Centers for Disease Control and Prevention (CDC) abruptly eliminated $200,000 in annual HIV ...

In Part 1 of this Spotlight special briefing, we looked at some of the big picture dynamics of HIV in South Africa, and in ...

The Trump administration is planning to eliminate the Centers for Disease Control and Prevention’s Division of HIV Prevention. The collapse of HIV prevention will mean 143,000 additional people in the ...

With a 500-percent surge in new human immunodeficiency virus or HIV cases per day, the Philippines now has the ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

The Provincial Government of Pampanga has announced the availability of Human Immunodeficiency Virus (HIV) testing and treatment centers across the province. Th ...

As government clinics take on HIV patients who were previously treated by Pepfar-funded projects, the treatment of conditions like diabetes and heart disease will come under pressure ...

Eight million people living with HIV. Just over 6 million on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor ...

National HIV Testing Day has been recognized every year since 1995 to encourage HIV testing, something Pinnacle Health said ...